reserpine has been researched along with nylidrin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Coffman, JD | 3 |
El-Gendi, MA; El-Shazly, MK; Geumei, A; Issa, I; Sadek, AM | 1 |
Abel, PW; Fox, AW; Minneman, KP | 1 |
3 review(s) available for reserpine and nylidrin
Article | Year |
---|---|
Drug therapy: vasodilator drugs in peripheral vascular disease.
Topics: Cyclandelate; Ethanol; Guanethidine; Humans; Isoxsuprine; Methyldopa; Nicotinic Acids; Nylidrin; Papaverine; Reserpine; Sympathetic Nervous System; Tolazoline; Vascular Diseases; Vasodilator Agents | 1979 |
Vasodilator drugs in peripheral vascular disease.
Topics: Animals; Arterial Occlusive Diseases; Cyclandelate; Ergot Alkaloids; Humans; Ischemia; Isoxsuprine; Methyldopa; Nicotinic Acids; Nylidrin; Papaverine; Regional Blood Flow; Reserpine; Tolazoline; Vascular Diseases; Vasodilator Agents | 1975 |
Vasodilator drugs in peripheral vascular disease.
Topics: Arterial Occlusive Diseases; Cyclandelate; Ergot Alkaloids; Ethanol; Guanethidine; Humans; Ischemia; Isoxsuprine; Methyldopa; Nicotinic Acids; Nylidrin; Papaverine; Research Design; Reserpine; Sympathetic Nervous System; Tolazoline; Vascular Diseases; Vasodilator Agents | 1975 |
4 other study(ies) available for reserpine and nylidrin
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Beta-adrenergic receptors and the effect of beta-adrenergic blocking agent propranolol on histamine and reserpine stimulated gastric acid secretion in man: normals and duodenal ulcer cases.
Topics: Adult; Dose-Response Relationship, Drug; Duodenal Ulcer; Gastric Juice; Gastric Mucosa; Histamine; Humans; Male; Nylidrin; Propranolol; Receptors, Adrenergic; Reserpine | 1976 |
Effects of isoxuprine and nylidrin on adrenoreceptors in rat vas deferens.
Topics: Animals; Binding, Competitive; In Vitro Techniques; Isoxsuprine; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nylidrin; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Reserpine; Vas Deferens | 1985 |